EUVIMEDEUVIMED entdecken
Crossref

Colorado Insulin Copay Cap: Lower Out-Of-Pocket Payments, Increased Prescription Volume And Days’ Supply

Benjamin D Ukert, Theodoros V Giannouchos, Thomas C Buchmueller

Health Affairs · 2024

DOI: 10.1377/hlthaff.2023.01592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Benjamin D Ukert und 2 weiteren Autor:innen. Beteiligte Einrichtung: Benjamin D. Ukert (bukert@tamu.edu), Texas A&M University, College Station, Texas, and Elevance Health, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Insulin, Health Expenditures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2020, Colorado became the first state to cap out-of-pocket spending for insulin prescriptions, requiring fully insured health plans to cap out-of-pocket spending at $100 for a thirty-day supply. We provide the first evidence on the association of Colorado's Insulin Affordability Program with patient out-of-pocket spending, the amounts paid by plans per insulin prescription, and prescription filling. Using statewide claims data from the period 2018-21, we focused on the first two years that the copay cap law was in effect. We found that Colorado's Insulin Affordability Program was associated with significant reductions in out-of-pocket spending for insulin prescriptions, with the mean out-of-pocket payment per thirty-day supply falling nearly in half (from $62.59 to $35.64). Average plan payments increased slightly more ($31.39) than the decrease in out-of-pocket spending, as the total amount paid per prescription increased by about 1 percent. The average insulin user realized annual savings of $184, while the mean number of fills and the mean days' supply per year increased by 4.2 percent and 11.4 percent, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinHealth ExpendituresHumansColoradoHypoglycemic AgentsFemaleMaleMiddle AgedCost SharingDrug CostsAdult

Substanzen

InsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Benjamin D. Ukert (bukert@tamu.edu), Texas A&M University, College Station, Texas, and Elevance Health, Indianapolis, Indiana.
  • Theodoros V. Giannouchos, University of Alabama at Birmingham, Birmingham, Alabama.
  • Thomas C. Buchmueller, Department of Health and Human Services, Washington, D.C., and University of Michigan. Ann Arbor, Michigan.

Zitieren

APA

Ukert, B. D., Giannouchos, T. V., & Buchmueller, T. C. (2024). Colorado Insulin Copay Cap: Lower Out-Of-Pocket Payments, Increased Prescription Volume And Days’ Supply. Health Affairs. https://doi.org/10.1377/hlthaff.2023.01592

Vancouver

Ukert BD, Giannouchos TV, Buchmueller TC. Colorado Insulin Copay Cap: Lower Out-Of-Pocket Payments, Increased Prescription Volume And Days’ Supply. Health Affairs. 2024. doi:10.1377/hlthaff.2023.01592

BibTeX
@article{Ukert2024,
  author = {Ukert, Benjamin D and Giannouchos, Theodoros V and Buchmueller, Thomas C},
  title = {Colorado Insulin Copay Cap: Lower Out-Of-Pocket Payments, Increased Prescription Volume And Days’ Supply},
  journal = {Health Affairs},
  year = {2024},
  doi = {10.1377/hlthaff.2023.01592}
}
Kostenlos starten →